Coverage Search vs ASCCP Management Guidelines

Your single source of reliable and current drug coverage and restriction information. “Need to know if that drug is covered? Are you a prescribing doc and want to select a preferred drug for your patient?” MMIT’s drug status information is updated nightly, ensuring you have the data points needed to guide prescribing decisions for your patients. Quickly understand how every health plan and PBM covers all FDA approved medications in your geography. App of the Week by Drug Store News | Top 50 Healthcare apps for Clinicians and Consumers to Know by Becker's Healthcare “Clearly the best choice in taking out the guess work of selecting medications and offering alternative choices for your patients. It has clearly reduced staff time getting authorizations… one of the few solutions out of this morass and does a better job than our EHR system or anything else I’ve seen.” “This is a must have for primary care providers.” Plan Features • Over 6,500 health plans representing over 98% of U.S. insured lives • Search commercial, Medicare Part D, State & Managed Medicaid and health exchange plans • Includes comprehensive set of Pharmacy Benefit Managers (PBM) and health plans • Drill down to the plan level to view detailed coverage information • Review in-depth restriction criteria for an initial group of Payers and PBMs that are working with MMIT • View differences in coverage across various forms and strengths of drugs • Save frequently accessed plans to your “Favorites” list Drug Features • View drug access across location and channel by percent of covered lives • Search coverage information by various forms of a drug • Quickly lookup alternative drug’s coverage information • Save frequently accessed products to your “Favorites” list Search Features • Enable Location Services to populate your plan list automatically • Quickly search by health plan or PBM name • Sort results by health plan name, covered lives, or coverage status

The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.